Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 3

2(28.6%)

Phase 2

2(28.6%)

7Total

N/A(3)

Phase 3(2)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07091279Phase 2Recruiting

Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism

Role: collaborator

NCT07092280Not ApplicableRecruiting

Transcranial Direct Current Stimulation in Children With Autism

Role: lead

NCT06259201Not ApplicableWithdrawn

Vagus Nerve Stimulator for Autism and Other Developmental Disorders

Role: lead

NCT04047355Phase 2Completed

Propranolol for Challenging Behaviors in Autism

Role: collaborator

NCT05105126Not ApplicableWithdrawn

Non-invasive Brain Stimulation in Children With Autism

Role: collaborator

NCT01594346Phase 3Completed

Multicenter Vitamin E Trial in Aging Persons With Down Syndrome

Role: lead

NCT00056329Phase 3Unknown

Vitamin E in Aging Persons With Down Syndrome

Role: lead

All 7 trials loaded